Data / Form D filings / OriGene Technologies, Inc.
OriGene Technologies, Inc.: Form D filings
OriGene Technologies, Inc., a biotechnology company in Rockville, MD, filed 4 Form D notices with the SEC between 2012 and 2015. The latest, on June 9, 2015, reports $17.1 million sold of a $32.1 million offering to 5 investors.
Find out what OriGene Technologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9620 MEDICAL CENTER DRIVE, SUITE 200, Rockville, MD, 20850
- Phone
- (301) 340-3188
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1557269
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2015 | New notice | $32,050,000 | $17,051,983 | $14,998,017 | 5 | May 26, 2015 | sec.gov |
| Mar 10, 2014 | New notice | $200,000 | $200,000 | $0 | 5 | Feb 24, 2014 | sec.gov |
| Mar 19, 2013 | New notice | $6,377,442 | $6,377,442 | $0 | 5 | Mar 7, 2013 | sec.gov |
| Sep 4, 2012 | New notice | $15,000,000 | $15,000,000 | $0 | 5 | Aug 21, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wei-Wu He | Executive Officer, Director | |
| Beatrice Leung | Director | |
| Tom Bluth | Director | |
| Anil Gupta | Director | |
| Karl Kovacs | Executive Officer | |
| Youmin Shu | Executive Officer | |
| Lanchun Duan | Director | |
| James Hu | Executive Officer | |
| Quan Zhou | Director | |
| Ellen Shih | Director | |
| Amy Tang | Director | |
| Rich Hamer | Executive Officer |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Jun 8, 2015 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OriGene Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.